India to launch indigenous vaccine against cervical cancer today
India to launch indigenous vaccine against cervical cancer today
India's first indigenously developed quadrivalent human papilloma virus (HPV) vaccine
India's first indigenously developed quadrivalent human papilloma virus (HPV) vaccine
The launch for the prevention of cervical cancer will be launched here on Thursday, officials said on Wednesday.
The launch for the prevention of cervical cancer will be launched here on Thursday, officials said on Wednesday.
Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer.
Serum Institute of India (SII) to manufacture an indigenously-developed vaccine against cervical cancer.
SII CEO Adar Poonawalla will be present at the event, officials said.
SII CEO Adar Poonawalla will be present at the event, officials said.
According to officials, qHPV vaccine CERVAVAC has demonstrated strong antibody response
According to officials, qHPV vaccine CERVAVAC has demonstrated strong antibody response
Approximately 1,000 times higher than baseline for all target HPV types and across all dose and age groups.
Approximately 1,000 times higher than baseline for all target HPV types and across all dose and age groups.
Cervical cancer is the second most frequent cancer in women in the age group of 15 to 44 years in India.
Cervical cancer is the second most frequent cancer in women in the age group of 15 to 44 years in India.
DCGI's approval came after the recommendation of the Subject Expert Committee (SEC).
DCGI's approval came after the recommendation of the Subject Expert Committee (SEC).
DCGI is seeking market authorization of QHPV after the completion of Phase II and III clinical trials in collaboration with Department of Biotechnology
DCGI is seeking market authorization of QHPV after the completion of Phase II and III clinical trials in collaboration with Department of Biotechnology